Role of cannabinoids in the development of fatty liver (steatosis)
about
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsFatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.Endocannabinoid tone versus constitutive activity of cannabinoid receptors.L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function.Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol.Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers.Cannabis in sport: anti-doping perspective.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet.Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model.Δ9-Tetrahydrocannabinol Induces Endocannabinoid Accumulation in Mouse Hepatocytes: Antagonism by Fabp1 Gene Ablation.Action of the chemical agent fipronil (active ingredient of acaricide Frontline®) on the liver of mice: an ultrastructural analysis.Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLDExercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits
P2860
Q26850858-2A64DF03-C57C-40E4-A97E-6D6459D860A7Q27009466-F8554CD0-E467-4CEA-9A28-53499CD66F8BQ33613330-D8115224-A7F7-4013-B553-228FCE601909Q34538205-3E32DE4B-03E7-412F-B7C5-15547FC5D4C3Q35193265-1F5D68C4-88DF-4A0C-AC78-5EDBFE6E4574Q35580023-72BFC573-3448-45E2-878E-4B09946F40F3Q35895832-1B7FCB99-5D60-4E46-87D1-6DF7733247CAQ36026554-8DD988E0-3778-4867-A734-8F7A8F8D86EFQ36742010-ED00AB4E-3D43-4E24-AC59-C81EC88C7C3FQ37029485-88409D23-9D72-4C3F-8C34-1D408EEE9A0CQ38503842-F36DCCA6-91E6-4250-9B09-F3980F89140EQ38939502-AC1B718D-DB81-42B9-806B-1184401C9D8FQ41969545-AD93D0CC-9A51-49BC-B03C-1A2959071AA7Q45064430-8CB31813-0A8B-4F98-9E10-F40107CBAAFAQ47621729-65C5C3B7-745F-480A-80CE-14A998473FB2Q48018603-FB6EE74E-53FE-40C4-9F3D-068BD70570E2Q50134192-DDEACAE9-FA8C-4783-A428-103FD0857AB1Q52724523-C8D87D5C-46C2-4890-8020-5F72DFF522E1Q55282555-942C8A53-EDED-4A7F-950D-F73FE83BC758Q55452630-3F8529A2-C761-4AA1-9108-E3D5DF80E2CDQ58753073-C49C8C7A-1AA7-46B4-B53B-14D68DC08FBAQ58776750-BFC021C7-6EF4-48E3-9783-F5F9E296F24E
P2860
Role of cannabinoids in the development of fatty liver (steatosis)
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of cannabinoids in the development of fatty liver (steatosis)
@ast
Role of cannabinoids in the development of fatty liver (steatosis)
@en
type
label
Role of cannabinoids in the development of fatty liver (steatosis)
@ast
Role of cannabinoids in the development of fatty liver (steatosis)
@en
prefLabel
Role of cannabinoids in the development of fatty liver (steatosis)
@ast
Role of cannabinoids in the development of fatty liver (steatosis)
@en
P2093
P2860
P1433
P1476
Role of cannabinoids in the development of fatty liver (steatosis)
@en
P2093
David Shurtleff
Rao Rapaka
Vishnudutt Purohit
P2860
P2888
P304
P356
10.1208/S12248-010-9178-0
P407
P577
2010-03-05T00:00:00Z
P5875
P6179
1037726315